|
|
|
ATH1-121501:264298_AT |
phospholipid/glycerol acyltransferase family protein |
at |
CANINE:1584718_AT |
similar to tafazzin isoform 4 |
cfa |
CANINE:1596823_AT |
similar to tafazzin isoform 4 |
cfa |
CANINE:1584719_S_AT |
similar to tafazzin isoform 4 |
cfa |
CANINE_2:CFA.4415.2.A1_AT |
similar to tafazzin isoform 4 |
cfa |
CANINE_2:CFA.4415.2.A1_X_AT |
similar to tafazzin isoform 4 |
cfa |
CANINE_2:CFAAFFX.29930.1.S1_S_AT |
similar to tafazzin isoform 4 |
cfa |
CANINE_2:CFAAFFX.29935.1.S1_AT |
similar to tafazzin isoform 4 |
cfa |
CANINE_2:CFAAFFX.29935.1.S1_S_AT |
similar to tafazzin isoform 4 |
cfa |
DROSOPHILA_2:1626481_A_AT |
|
dm |
DROSGENOME1:144150_AT |
|
dm |
HG-U133_PLUS_2:203977_AT |
tafazzin (cardiomyopathy, dilated 3A (X-linked); endocardial fibroelastosis 2; Barth syndrome) |
hs |
HG-U133A:203977_AT |
tafazzin (cardiomyopathy, dilated 3A (X-linked); endocardial fibroelastosis 2; Barth syndrome) |
hs |
HG-U133A_2:203977_AT |
tafazzin (cardiomyopathy, dilated 3A (X-linked); endocardial fibroelastosis 2; Barth syndrome) |
hs |
HUGENEFL:X92762_AT |
tafazzin (cardiomyopathy, dilated 3A (X-linked); endocardial fibroelastosis 2; Barth syndrome) |
hs |
U133_X3P:G4507370_3P_X_AT |
tafazzin (cardiomyopathy, dilated 3A (X-linked); endocardial fibroelastosis 2; Barth syndrome) |
hs |
U133_X3P:G4507370_3P_S_AT |
tafazzin (cardiomyopathy, dilated 3A (X-linked); endocardial fibroelastosis 2; Barth syndrome) |
hs |
U133_X3P:G4507370_3P_AT |
tafazzin (cardiomyopathy, dilated 3A (X-linked); endocardial fibroelastosis 2; Barth syndrome) |
hs |
U133_X3P:4875649_3P_S_AT |
tafazzin (cardiomyopathy, dilated 3A (X-linked); endocardial fibroelastosis 2; Barth syndrome) |
hs |
U133_X3P:37278_3P_AT |
tafazzin (cardiomyopathy, dilated 3A (X-linked); endocardial fibroelastosis 2; Barth syndrome) |
hs |
U133_X3P:203977_3P_AT |
tafazzin (cardiomyopathy, dilated 3A (X-linked); endocardial fibroelastosis 2; Barth syndrome) |
hs |
HG-U133A_2:37278_AT |
tafazzin (cardiomyopathy, dilated 3A (X-linked); endocardial fibroelastosis 2; Barth syndrome) |
hs |
HG-FOCUS:37278_AT |
tafazzin (cardiomyopathy, dilated 3A (X-linked); endocardial fibroelastosis 2; Barth syndrome) |
hs |
HG-U133_PLUS_2:37278_AT |
tafazzin (cardiomyopathy, dilated 3A (X-linked); endocardial fibroelastosis 2; Barth syndrome) |
hs |
HG-U133A:37278_AT |
tafazzin (cardiomyopathy, dilated 3A (X-linked); endocardial fibroelastosis 2; Barth syndrome) |
hs |
HG-U95AV2:37278_AT |
tafazzin (cardiomyopathy, dilated 3A (X-linked); endocardial fibroelastosis 2; Barth syndrome) |
hs |
HG-U95D:84938_R_AT |
Tafazzin (cardiomyopathy, dilated 3A (X-linked); endocardial fibroelastosis 2; Barth syndrome) |
hs |
MOUSE430_2:1453785_AT |
tafazzin |
mm |
MOE430B:1453785_AT |
tafazzin |
mm |
MG-U74BV2:107572_AT |
tafazzin |
mm |
MG-U74BV2:165308_F_AT |
tafazzin |
mm |
MOE430A:1416207_AT |
tafazzin |
mm |
MOUSE430A_2:1416207_AT |
tafazzin |
mm |
MOUSE430_2:1416207_AT |
tafazzin |
mm |
MU19KSUBA:TC22079_AT |
Tafazzin, mRNA (cDNA clone MGC:19336 IMAGE:4221041) |
mm |
MU19KSUBB:TC31988_AT |
Tafazzin, mRNA (cDNA clone MGC:19336 IMAGE:4221041) |
mm |
RG-U34C:RC_AI172122_AT |
tafazzin (cardiomyopathy, dilated 3A (X-linked); endocardial fibroelastosis 2; Barth syndrome) |
rn |
RAE230A:1372008_AT |
tafazzin (cardiomyopathy, dilated 3A (X-linked); endocardial fibroelastosis 2; Barth syndrome) |
rn |
RAT230_2:1372008_AT |
tafazzin (cardiomyopathy, dilated 3A (X-linked); endocardial fibroelastosis 2; Barth syndrome) |
rn |
RAE230B:1380623_AT |
tafazzin (cardiomyopathy, dilated 3A (X-linked); endocardial fibroelastosis 2; Barth syndrome) |
rn |
RAT230_2:1380623_AT |
tafazzin (cardiomyopathy, dilated 3A (X-linked); endocardial fibroelastosis 2; Barth syndrome) |
rn |
YEAST_2:1771401_AT |
Lyso-phosphatidylcholine acyltransferase, required for normal phospholipid content of mitochondrial membranes; may remodel acyl groups of cardiolipin in the inner membrane; similar to human tafazzin, which is implicated in Barth syndrome |
Sc |